Novartis opens the books. This is what experts from the figures expect.
Novartis will present the quarterly figures for the latest annual quarter – final date 30.06.2025 – in the financial conference.
The forecasts of 10 analysts for the latest annual quarter amount to an EPS of USD 2.35 per share. A year earlier, Novartis had a profit per share of CHF 1.45 in the books.
Based on the estimates of 8 analysts, sales are expected to reach $ 14.07 billion in the recent quarter, compared to sales of CHF 11.32 billion in the previous year.
For the fiscal year, 20 analysts now expect an average profit per share of $ 8.68 compared to CHF 5.21 in the previous year. 19 analysts see the turnover of $ 54.77 billion, compared to $ 44.31 billion last year.
Editor finance.net
Selected leverage products on Novartis
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Novartis
The lever must be between 2 and 20
Advertising